Sarcopenic obesity and skeletal development in children: recent advances - Report - MDSpire

Sarcopenic obesity and skeletal development in children: recent advances

  • By

  • Yumo Liu

  • Xinyu Li

  • Xuhan Liu

  • July 13, 2026

Share

Clinical Report: Recent Insights into Sarcopenic Obesity and Bone Development

Background

Childhood obesity is a significant global health issue, affecting over 340 million children and adolescents. Sarcopenic obesity, defined by the coexistence of excess fat and reduced muscle mass, complicates the health of children and adolescents, particularly concerning their skeletal development. Understanding the implications of SO is crucial for timely prevention and intervention strategies.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Sarcopenic obesity negatively influences physical development and skeletal health in children.
  • SO is characterized by increased adiposity and decreased muscle mass, which interact to worsen skeletal fragility.
  • Obesity-related factors can suppress bone formation while accelerating bone resorption.
  • Children with obesity often present with impaired bone development and decreased bone density.
  • Inadequate bone accumulation during peak bone mass acquisition can lead to long-term skeletal issues.

Clinical Implications

Healthcare professionals should be aware of the complex relationship between obesity, muscle mass, and bone health in pediatric patients. Early detection and management of sarcopenic obesity are essential to mitigate long-term skeletal health risks.

Conclusion

Sarcopenic obesity presents significant challenges in pediatric populations, necessitating further research and effective intervention strategies to support healthy growth and development.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Frontiers in Endocrinology, 2026 -- Artificial intelligence-driven assessment of sarcopenia in orthopedic geriatrics: technical progress and clinical implications
  3. Frontiers in Endocrinology, 2026 -- Lymphatic dysfunction and impaired interstitial clearance in sarcopenic obesity: a hypothesis-generating review
  4. Osteosarcopenic obesity: A systematic review and a call for consensus on definitions and diagnostic criteria - ScienceDirect
  5. Sarcopenia in pediatric gastroenterology and hepatology: an updated review - PubMed
  6. Handgrip Strength Thresholds to Detect Cardiometabolic Risk in Youth: Cross‐Sectional Study and Meta‐Analysis - PMC
  7. Impact of Sarcopenia on Major Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancies: A Retrospective Cohort Analysis
  8. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity | Pediatrics | American Academy of Pediatrics
  9. A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial | Nature Communications
  10. Osteosarcopenic obesity: A systematic review and a call for consensus on definitions and diagnostic criteria - ScienceDirect
  11. Sarcopenia in pediatric gastroenterology and hepatology: an updated review - PubMed
  12. Handgrip Strength Thresholds to Detect Cardiometabolic Risk in Youth: Cross‐Sectional Study and Meta‐Analysis - PMC
  13. Text Pediatric Positions - ISCD

Original Source(s)

Related Content